Mark Garzotto
Professor of Urology, School of Medicine · Oregon Health & Science University
Credentials: · · ·
History
Research
Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation
The Journal of Experimental Medicine · 1997 · 355 citations
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer
Cancer Research · 2010 · 302 citations
Journal of Clinical Oncology · 2014 · 250 citations
- TB
53 papers
- CH
14 papers
- RK
10 papers · 1 as a fellow
- CR
7 papers
6 papers
6 papers
5 papers
- AH
5 papers
Grants
- 2007–2013
The Pacific Northwest Prostate Cancer SPORE
National Cancer Institute · P50
Project lead · $1.4M · Fred Hutchinson Cancer Center
Clinical trials
- 2018–2023
Principal investigator · Recruiting · Phase 2
Mark Garzotto, MD
- 2017–2018
- 2007–2017
Statin Therapy Versus Placebo Prior to Prostatectomy
Principal investigator · Completed
VA Office of Research and Development
- 2006–2023
Principal investigator · Terminated · Phase 1, Phase 2
OHSU Knight Cancer Institute